Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

Overview of attention for article published in Arthritis Research & Therapy, April 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 8 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 4 additional patents.